Monkeypox transmission among international travellers-serious monkey business?
J Travel Med
.
2019 Jun 11;26(5):taz002.
doi: 10.1093/jtm/taz002.
Authors
Kristina M Angelo
1
,
Brett W Petersen
2
,
Davidson H Hamer
3
4
,
Eli Schwartz
5
6
,
Gary Brunette
1
Affiliations
1
Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA.
2
Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
3
Department of Global Health, Boston University School of Public Health, Boston, MA, USA.
4
Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, MA, USA.
5
Center for Geographical Medicine, Sheba Medical Center, Tel-Hashomer, Israel.
6
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
PMID:
30657959
PMCID:
PMC6682460
DOI:
10.1093/jtm/taz002
No abstract available
Publication types
Editorial
MeSH terms
Animals
Humans
Mpox (monkeypox) / epidemiology
Mpox (monkeypox) / transmission*
Travel*
Grants and funding
CC999999/Intramural CDC HHS/United States
U50 CK000189/CK/NCEZID CDC HHS/United States